review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Thomas Friedrich | |
Kirstin Hobiger | |||
P2860 | cites work | Voltage-Controlled Enzymes: The New JanusBifrons | Q21129281 |
The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 | ||
Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA 5'-triphosphatase and diphosphatase activities | Q22009915 | ||
A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y | Q22010933 | ||
Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes | Q24290296 | ||
Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation | Q24290536 | ||
Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation | Q24290901 | ||
Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation | Q24297363 | ||
TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta | Q24310394 | ||
Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins | Q24314904 | ||
The purification and characterization of a human dual-specific protein tyrosine phosphatase | Q24315749 | ||
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
PIR1, a novel phosphatase that exhibits high affinity to RNA . ribonucleoprotein complexes | Q24318882 | ||
Structure of human PIR1, an atypical dual-specificity phosphatase | Q24321790 | ||
Coupling of the phosphatase activity of Ci-VSP to its voltage sensor activity over the entire range of voltage sensitivity | Q48676430 | ||
What if higher plants lack a CDC25 phosphatase? | Q49074647 | ||
Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate | Q50335611 | ||
Gene expression profile of Ci-VSP in juveniles and adult blood cells of ascidian. | Q51892982 | ||
The catalytic acid in the dephosphorylation of the Cdk2-pTpY/CycA protein complex by Cdc25B phosphatase. | Q54791217 | ||
The 18 kDa cytosolic acid phosphatase from bovine liver has phosphotyrosine phosphatase activity on the autophosphorylated epidermal growth factor receptor | Q58199761 | ||
Aspartic-129 is an essential residue in the catalytic mechanism of the low M r phosphotyrosine protein phosphatase | Q58291404 | ||
Red Cell Acid Phosphatase Variants: A New Human Polymorphism | Q59068918 | ||
Leaving group dependence and proton inventory studies of the phosphorylation of a cytoplasmic phosphotyrosyl protein phosphatase from bovine heart | Q68253861 | ||
The molecular basis of the differing kinetic behavior of the two low molecular mass phosphotyrosine protein phosphatase isoforms | Q70937660 | ||
The catalytic role of aspartic acid-92 in a human dual-specific protein-tyrosine-phosphatase | Q72607148 | ||
Comparative kinetic analysis and substrate specificity of the tandem catalytic domains of the receptor-like protein-tyrosine phosphatase alpha | Q73119344 | ||
Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1 | Q73243848 | ||
Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2 | Q73836216 | ||
Dual-specific Cdc25B phosphatase: in search of the catalytic acid | Q74290644 | ||
Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation | Q74457509 | ||
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases | Q24323070 | ||
14-3-3 proteins associate with cdc25 phosphatases | Q24324041 | ||
Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR | Q24556532 | ||
Expression cloning of a human dual-specificity phosphatase | Q24562377 | ||
A catalytic mechanism for the dual-specific phosphatases | Q24563405 | ||
Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. | Q24647903 | ||
Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Q24653458 | ||
PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration | Q24677034 | ||
ER-bound protein tyrosine phosphatase PTP1B interacts with Src at the plasma membrane/substrate interface | Q27301222 | ||
The structure of the bovine protein tyrosine phosphatase dimer reveals a potential self-regulation mechanism | Q27619897 | ||
Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle | Q27620131 | ||
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association | Q27620298 | ||
Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate | Q27641430 | ||
Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B | Q27641431 | ||
Insights into the Reaction of Protein-tyrosine Phosphatase 1B: CRYSTAL STRUCTURES FOR TRANSITION STATE ANALOGS OF BOTH CATALYTIC STEPS | Q27660261 | ||
Crystal Structure of the Cytoplasmic Phosphatase and Tensin Homolog (PTEN)-like Region of Ciona intestinalis Voltage-sensing Phosphatase Provides Insight into Substrate Specificity and Redox Regulation of the Phosphoinositide Phosphatase Activity | Q27667692 | ||
A glutamate switch controls voltage-sensitive phosphatase function | Q27678935 | ||
Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates | Q27685301 | ||
Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2-A resolution | Q27729419 | ||
Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B | Q27729426 | ||
Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate | Q27730850 | ||
The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase | Q27730852 | ||
Crystal structure of human protein tyrosine phosphatase 1B | Q27731235 | ||
Crystal structure of the dual specificity protein phosphatase VHR | Q27732778 | ||
Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by x-ray crystallography | Q27749490 | ||
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A | Q27757908 | ||
Crystal structure of a human low molecular weight phosphotyrosyl phosphatase. Implications for substrate specificity | Q27765114 | ||
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
PTEN and myotubularin: novel phosphoinositide phosphatases | Q27937321 | ||
Sequencing, cloning, and expression of human red cell-type acid phosphatase, a cytoplasmic phosphotyrosyl protein phosphatase | Q28115861 | ||
Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates | Q28116113 | ||
PTEN: The down side of PI 3-kinase signalling. | Q34540849 | ||
Oxidants painting the cysteine chapel: redox regulation of PTPs | Q34552511 | ||
Purification of the major protein-tyrosine-phosphatases of human placenta | Q34554142 | ||
Characterization of the major protein-tyrosine-phosphatases of human placenta. | Q34554150 | ||
Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane | Q34574432 | ||
A role for the noncatalytic N terminus in the function of Cdc25, a Saccharomyces cerevisiae Ras-guanine nucleotide exchange factor. | Q34609218 | ||
Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. | Q34648275 | ||
Pten signaling in gliomas | Q34707865 | ||
Enzyme domain affects the movement of the voltage sensor in ascidian and zebrafish voltage-sensing phosphatases | Q34765642 | ||
Low molecular weight protein tyrosine phosphatases: small, but smart. | Q34777984 | ||
A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate | Q34784803 | ||
Targeting protein tyrosine phosphatases for anticancer drug discovery | Q34789961 | ||
Ci-VSP is a depolarization-activated phosphatidylinositol-4,5-bisphosphate and phosphatidylinositol-3,4,5-trisphosphate 5'-phosphatase | Q34891762 | ||
The linker pivot in Ci-VSP: the key to unlock catalysis | Q34906624 | ||
Controlling the activity of a phosphatase and tensin homolog (PTEN) by membrane potential. | Q34979031 | ||
CD45: a critical regulator of signaling thresholds in immune cells | Q34987899 | ||
The two faces of PTP1B in cancer | Q35005347 | ||
Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance | Q35023360 | ||
Dissecting the catalytic mechanism of protein-tyrosine phosphatases | Q35063279 | ||
Membrane-binding and activation mechanism of PTEN. | Q35145882 | ||
Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation | Q35146110 | ||
Implication of phosphoinositide phosphatases in genetic diseases: the case of myotubularin | Q35584128 | ||
Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling | Q35689670 | ||
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer | Q35861503 | ||
Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates | Q35933396 | ||
Functions and mechanisms of redox regulation of cysteine-based phosphatases | Q36124979 | ||
Redox redux: revisiting PTPs and the control of cell signaling | Q36151514 | ||
Evolution of the voltage sensor domain of the voltage-sensitive phosphoinositide phosphatase VSP/TPTE suggests a role as a proton channel in eutherian mammals | Q36179844 | ||
Redox regulation of PI 3-kinase signalling via inactivation of PTEN | Q36266420 | ||
Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45 | Q36403197 | ||
Cdc25: mechanisms of checkpoint inhibition and recovery | Q36471975 | ||
Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction | Q36544446 | ||
Emerging roles of nuclear protein phosphatases | Q36743535 | ||
Cdc25 phosphatases: structure, specificity, and mechanism | Q36747424 | ||
Phosphorylation and activation of human cdc25-C by cdc2--cyclin B and its involvement in the self-amplification of MPF at mitosis | Q34040409 | ||
Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer | Q34087341 | ||
Synthesis and biological evaluation of phosphatidylinositol phosphate affinity probes | Q34089143 | ||
Family ties of gated pores: evolution of the sensor module | Q34153984 | ||
Combinatorial control of the specificity of protein tyrosine phosphatases | Q34180660 | ||
Voltage sensitive phosphoinositide phosphatases of Xenopus: their tissue distribution and voltage dependence | Q34187806 | ||
3' Phosphatase activity toward phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] by voltage-sensing phosphatase (VSP) | Q34278006 | ||
Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signaling pathway | Q34279545 | ||
A human phospholipid phosphatase activated by a transmembrane control module | Q34294291 | ||
Protein tyrosine phosphatases as potential therapeutic targets | Q34295063 | ||
Functional diversity of voltage-sensing phosphatases in two urodele amphibians | Q34297477 | ||
Protein tyrosine phosphatases: prospects for therapeutics | Q34318066 | ||
Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. | Q34328870 | ||
Substrate-trapping techniques in the identification of cellular PTP targets | Q34374862 | ||
Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor | Q34419859 | ||
Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy | Q34444806 | ||
Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway | Q28142838 | ||
Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate | Q28186818 | ||
An overview of the protein tyrosine phosphatase superfamily | Q28188951 | ||
Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids | Q28203936 | ||
Cdc25C interacts with PCNA at G2/M transition | Q28207568 | ||
Cloning and characterization of mouse UBPy, a deubiquitinating enzyme that interacts with the ras guanine nucleotide exchange factor CDC25(Mm)/Ras-GRF1 | Q28212329 | ||
Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis | Q28242514 | ||
Protein tyrosine phosphatases in the human genome | Q28265924 | ||
Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase | Q28266581 | ||
The structure and mechanism of protein phosphatases: insights into catalysis and regulation | Q28275119 | ||
Cdc25 phosphatases and cancer | Q28278269 | ||
Protein tyrosine phosphatases: mechanisms of catalysis and regulation | Q28288979 | ||
Enzymatic detoxification of cyanide: clues from Pseudomonas aeruginosa Rhodanese | Q28289954 | ||
TPIP: a novel phosphoinositide 3-phosphatase | Q28364566 | ||
Dual mode of degradation of Cdc25 A phosphatase | Q28386155 | ||
Dephosphorylation of tyrosine phosphorylated synthetic peptides by rat liver phosphotyrosine protein phosphatase isoenzymes | Q28583016 | ||
The murine orthologue of the Golgi-localized TPTE protein provides clues to the evolutionary history of the human TPTE gene family | Q28588732 | ||
Rapid destruction of human Cdc25A in response to DNA damage | Q28611930 | ||
The TPTE gene family: cellular expression, subcellular localization and alternative splicing | Q28678657 | ||
A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen | Q29347520 | ||
Protein tyrosine phosphatases: from genes, to function, to disease | Q29614826 | ||
Reversible inactivation of the tumor suppressor PTEN by H2O2 | Q29615204 | ||
Prediction of a ligand-induced conformational change in the catalytic core of Cdc25A. | Q30325800 | ||
Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. | Q30441600 | ||
HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. | Q30828692 | ||
The cdk-activating kinase (CAK): from yeast to mammals. | Q33585306 | ||
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening | Q33600807 | ||
Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase. | Q33649199 | ||
The rhodanese/Cdc25 phosphatase superfamily. Sequence-structure-function relations | Q33758088 | ||
Electrochemical coupling in the voltage-dependent phosphatase Ci-VSP. | Q33802097 | ||
Phosphoinositide phosphatases in cell biology and disease | Q33862413 | ||
A novel isoform of the low molecular weight phosphotyrosine phosphatase, LMPTP-C, arising from alternative mRNA splicing | Q33862828 | ||
Genomic structure of a copy of the human TPTE gene which encompasses 87 kb on the short arm of chromosome 21. | Q33921281 | ||
PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase | Q33940647 | ||
Structural mechanism of voltage-dependent gating in an isolated voltage-sensing domain | Q33974931 | ||
Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B. | Q43966806 | ||
Catalytic mechanism of Cdc25. | Q44237172 | ||
Kidney specific expression of cTPTE during development of the chick embryo | Q44247237 | ||
cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. | Q44705461 | ||
Structural mechanism of oxidative regulation of the phosphatase Cdc25B via an intramolecular disulfide bond | Q44862123 | ||
Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. | Q45094371 | ||
Phosphatase activity of the voltage-sensing phosphatase, VSP, shows graded dependence on the extent of activation of the voltage sensor | Q45323409 | ||
Protein phosphorylation in signaling--50 years and counting | Q46541371 | ||
Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers | Q46612262 | ||
Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility to cancer development | Q46762835 | ||
PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes | Q46791213 | ||
The low-molecular-weight acid phosphatase from bovine liver: isolation, amino acid composition, and chemical modification studies | Q47287151 | ||
Site-directed mutagenesis, kinetic, and spectroscopic studies of the P-loop residues in a low molecular weight protein tyrosine phosphatase | Q47322995 | ||
Subcellular distribution of low- and high-molecular-weight acid phosphatases | Q47335093 | ||
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease | Q47343610 | ||
Asp129 of low molecular weight protein tyrosine phosphatase is involved in leaving group protonation | Q47367748 | ||
Reduction of low-molecular-weight acid phosphatase activity in Alzheimer brains | Q47392334 | ||
Cloning, expression and characterisation of a new human low Mr phosphotyrosine protein phosphatase originating by alternative splicing. | Q47763944 | ||
cdc25+ functions as an inducer in the mitotic control of fission yeast | Q48366414 | ||
The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture | Q48575949 | ||
Allergy and ACP1 genetic polymorphism | Q36772729 | ||
Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis | Q36799816 | ||
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery | Q36805716 | ||
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain | Q36818855 | ||
CDC25 phosphatases in cancer cells: key players? Good targets? | Q36849329 | ||
Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease | Q37094068 | ||
Protein tyrosine phosphatases: structure-function relationships | Q37094073 | ||
Glycogen and its metabolism: some new developments and old themes | Q37095413 | ||
Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations | Q37153228 | ||
Coupling between the voltage-sensing and phosphatase domains of Ci-VSP. | Q37267670 | ||
Evolution of protein phosphatases in plants and animals | Q37355920 | ||
Inflammatory bowel disease: Are there gender differences in the genetics of signal transduction? A preliminary study of cytosolic low molecular weight protein tyrosine phosphatase | Q37365173 | ||
PTP1B: a double agent in metabolism and oncogenesis | Q37728307 | ||
PI(3)king apart PTEN's role in cancer. | Q37771785 | ||
Voltage-sensing phosphatase: its molecular relationship with PTEN. | Q37847813 | ||
Regulation of protein tyrosine phosphatases by reversible oxidation | Q37920470 | ||
Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species | Q37979774 | ||
New insights in the activity of voltage sensitive phosphatases | Q38000457 | ||
Redox regulation of tumor suppressor PTEN in cancer and aging (Review). | Q38073546 | ||
Biochemistry and structure of phosphoinositide phosphatases | Q38076803 | ||
Protein tyrosine phosphatases: structure, function, and implication in human disease. | Q38122079 | ||
PTP1B: a simple enzyme for a complex world | Q38123537 | ||
PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease | Q38125356 | ||
The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. | Q38288824 | ||
Redox regulation of the tumor suppressor PTEN by glutathione | Q39679407 | ||
Differential redox regulation within the PTP superfamily | Q40161680 | ||
Redox regulation of PTEN by S-nitrosothiols | Q40406877 | ||
The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif | Q40601438 | ||
Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition | Q40793182 | ||
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation | Q40795994 | ||
The cdc25B phosphatase is essential for the G2/M phase transition in human cells | Q41021031 | ||
Structural, catalytic, and functional properties of low M(r), phosphotyrosine protein phosphatases. Evidence of a long evolutionary history. | Q41467925 | ||
Identification of an essential acidic residue in Cdc25 protein phosphatase and a general three-dimensional model for a core region in protein phosphatases | Q41492501 | ||
Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. | Q41501980 | ||
Structure and function of the low Mr phosphotyrosine protein phosphatases | Q41633407 | ||
The role of CD45 and CD45-associated molecules in T cell activation | Q41682334 | ||
Crystal structure of low-molecular-weight protein tyrosine phosphatase from Mycobacterium tuberculosis at 1.9-A resolution | Q42019139 | ||
Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth. | Q42169520 | ||
Coupling of Ci-VSP modules requires a combination of structure and electrostatics within the linker | Q42230567 | ||
Low molecular weight phosphotyrosine protein phosphatase from PC12 cells. Purification, some properties and expression during neurogenesis in vitro and in vivo | Q42442721 | ||
PTPRQ is a novel phosphatidylinositol phosphatase that can be expressed as a cytoplasmic protein or as a subcellularly localized receptor-like protein | Q42444048 | ||
A Tyr/Ser protein phosphatase encoded by vaccinia virus | Q42621801 | ||
Application of neural oscillators to study the effects of walking speed on rhythmic activations at the ankle | Q42738452 | ||
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling | Q42795847 | ||
The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. | Q42805494 | ||
Purification and characterization of a low-molecular-weight acid phosphatase--a phosphotyrosyl-protein phosphatase from bovine heart | Q43409433 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 20 | |
P577 | publication date | 2015-01-10 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | Voltage sensitive phosphatases: emerging kinship to protein tyrosine phosphatases from structure-function research | |
P478 | volume | 6 |
Q64910882 | A126 in the active site and TI167/168 in the TI loop are essential determinants of the substrate specificity of PTEN. |
Q36703549 | Allosteric substrate switching in a voltage-sensing lipid phosphatase |
Q41234223 | Editorial: Phosphoinositides and their phosphatases: Linking electrical and chemical signals in biological processes |
Q38968792 | Hysteresis in voltage-gated channels |
Q52655508 | Structural and biochemical characterization of Siw14: a protein-tyrosine phosphatase fold that metabolizes inositol pyrophosphates. |
Search more.